National Meeting of the American College of Rheumatology. November 8-12, 1998, San Diego, California

Clin Invest Med. 1999 Apr;22(2):63-4.
No abstract available

Publication types

  • Congress

MeSH terms

  • Aniline Compounds / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Etanercept
  • Humans
  • Hydroxybutyrates / pharmacology
  • Immunoglobulin G / therapeutic use
  • Immunoglobulin Heavy Chains*
  • Immunoglobulin gamma-Chains
  • Infliximab
  • Isoxazoles / therapeutic use
  • Leflunomide
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Recombinant Fusion Proteins / therapeutic use
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • United States

Substances

  • Aniline Compounds
  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Hydroxybutyrates
  • Immunoglobulin G
  • Immunoglobulin Heavy Chains
  • Immunoglobulin gamma-Chains
  • Isoxazoles
  • Receptors, Tumor Necrosis Factor
  • Recombinant Fusion Proteins
  • Tumor Necrosis Factor-alpha
  • A 771726
  • Ro 45-2081
  • Infliximab
  • Leflunomide
  • Etanercept